LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Halozyme Therapeutics
HALO
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
YETI Holdings
YETI
Dorian LPG
LPG
US Stock MarketDetailed Quotes
ANTX AN2 Therapeutics
- 1.440
- +0.060+4.35%
Close Dec 27 16:00 ET
- 1.440
- 0.000-0.01%
Post 20:01 ET
43.03MMarket Cap-0.72P/E (TTM)
1.450High1.390Low154.71KVolume1.390Open1.380Pre Close219.77KTurnover1.04%Turnover RatioLossP/E (Static)29.88MShares22.22052wk High0.49P/B21.52MFloat Cap0.87052wk Low--Dividend TTM14.94MShs Float23.580Historical High--Div YieldTTM4.35%Amplitude0.870Historical Low1.420Avg Price1Lot Size
AN2 Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | -24.55%93.43M | 9.74%104.54M | 29.03%114.21M | 11.70%107.3M | 11.70%107.3M | 18.62%123.82M | -15.99%95.26M | -25.21%88.52M | 64.05%96.06M | 64.05%96.06M |
| -Cash and cash equivalents | 2.72%33.5M | -34.41%26.77M | -7.55%24.69M | -42.51%15.65M | -42.51%15.65M | 13.24%32.62M | 0.48%40.81M | -67.63%26.71M | 125.01%27.22M | 125.01%27.22M |
| -Short-term investments | -34.30%59.92M | 42.84%77.77M | 44.84%89.52M | 33.13%91.65M | 33.13%91.65M | 20.67%91.2M | -25.18%54.45M | 72.47%61.81M | 48.18%68.84M | 48.18%68.84M |
| Other current assets | 64.53%4.26M | -1.70%2.9M | 16.77%2.1M | 25.37%3.21M | 25.37%3.21M | -11.08%2.59M | -15.48%2.95M | 26.03%1.8M | 65.18%2.56M | 65.18%2.56M |
| Total current assets | -22.72%97.69M | 9.40%107.44M | 28.78%116.31M | 12.05%110.51M | 12.05%110.51M | 17.81%126.41M | -15.97%98.21M | -24.60%90.32M | 64.08%98.62M | 64.08%98.62M |
| Non current assets | ||||||||||
| Investments and advances | --0 | --0 | --3.9M | 744.80%27.19M | 744.80%27.19M | 1,223.09%26.36M | --0 | --0 | -7.66%3.22M | -7.66%3.22M |
| Non current deferred assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --48K | ---- | ---- |
| Other non current assets | ---- | 44.86%1.04M | 44.86%1.04M | 44.86%1.04M | 44.86%1.04M | 44.86%1.04M | 0.00%720K | 0.00%720K | --720K | --720K |
| Total non current assets | --0 | 44.86%1.04M | 544.14%4.95M | 616.86%28.24M | 616.86%28.24M | 910.29%27.4M | -77.06%720K | 6.67%768K | -24.40%3.94M | -24.40%3.94M |
| Total assets | -36.49%97.69M | 9.66%108.48M | 33.13%121.26M | 35.28%138.74M | 35.28%138.74M | 39.82%153.81M | -17.57%98.93M | -24.41%91.08M | 57.02%102.56M | 57.02%102.56M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | -64.92%1.71M | -39.80%1.89M | -31.37%2.43M | 26.11%2.68M | 26.11%2.68M | 238.68%4.88M | 94.23%3.13M | 35.88%3.55M | 99.62%2.12M | 99.62%2.12M |
| -accounts payable | -64.92%1.71M | -39.80%1.89M | -31.37%2.43M | 26.11%2.68M | 26.11%2.68M | 238.68%4.88M | 94.23%3.13M | 35.88%3.55M | 99.62%2.12M | 99.62%2.12M |
| Current accrued expenses | -27.53%4.92M | -9.31%5.84M | 63.03%6.91M | 135.50%6.68M | 135.50%6.68M | 276.18%6.79M | 257.55%6.44M | 101.86%4.24M | 102.79%2.84M | 102.79%2.84M |
| Current debt and capital lease obligation | ---- | ---- | ---- | ---- | ---- | ---- | 0.00%13K | 6.25%34K | --53K | --53K |
| -Current capital lease obligation | ---- | ---- | ---- | --0 | --0 | --0 | 0.00%13K | 6.25%34K | --53K | --53K |
| Other current liabilities | 30.64%1.28M | 18,533.33%559K | 6,320.00%321K | 11,033.33%668K | 11,033.33%668K | 12,100.00%976K | -66.67%3K | -50.00%5K | -64.71%6K | -64.71%6K |
| Current liabilities | -32.50%10.02M | -9.26%10.13M | 24.48%10.66M | 95.42%14.04M | 95.42%14.04M | 234.81%14.84M | 169.00%11.16M | 68.39%8.57M | 111.66%7.19M | 111.66%7.19M |
| Non current liabilities | ||||||||||
| Derivative product liabilities | ---- | ---- | ---- | --0 | --0 | --0 | -75.00%1K | -83.33%1K | -84.62%2K | -84.62%2K |
| Total non current liabilities | --0 | --0 | --0 | --0 | --0 | --0 | -75.00%1K | -83.33%1K | -84.62%2K | -84.62%2K |
| Total liabilities | -32.50%10.02M | -9.27%10.13M | 24.47%10.66M | 95.37%14.04M | 95.37%14.04M | 234.59%14.84M | 168.77%11.16M | 68.21%8.57M | 110.92%7.19M | 110.92%7.19M |
| Shareholders'equity | ||||||||||
| Share capital | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| -common stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| -Preferred stock | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Retained earnings | -44.12%-198.25M | -53.50%-185.51M | -62.85%-171.07M | -72.15%-154.46M | -72.15%-154.46M | -76.62%-137.56M | -81.61%-120.85M | -86.18%-105.05M | -89.35%-89.72M | -89.35%-89.72M |
| Paid-in capital | 3.31%285.81M | 36.01%283.89M | 50.00%281.62M | 50.37%278.88M | 50.37%278.88M | 50.36%276.65M | 14.21%208.73M | 9.16%187.74M | --185.47M | --185.47M |
| Gains losses not affecting retained earnings | 191.80%112K | 77.31%-27K | 130.29%53K | 173.53%275K | 173.53%275K | 77.45%-122K | 66.94%-119K | -10.76%-175K | -1,285.19%-374K | -1,285.19%-374K |
| Total stockholders'equity | -36.91%87.67M | 12.07%98.35M | 34.03%110.6M | 30.75%124.7M | 30.75%124.7M | 31.63%138.97M | -24.25%87.76M | -28.50%82.52M | 54.05%95.37M | 54.05%95.37M |
| Total equity | -36.91%87.67M | 12.07%98.35M | 34.03%110.6M | 30.75%124.7M | 30.75%124.7M | 31.63%138.97M | -24.25%87.76M | -28.50%82.52M | 54.05%95.37M | 54.05%95.37M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |